Jan De Witte - May 15, 2024 Form 4/A Insider Report for RESMED INC (RMD)

Role
Director
Signature
Jan De Witte, director
Stock symbol
RMD
Transactions as of
May 15, 2024
Transactions value $
-$78,584
Form type
4/A
Date filed
5/22/2024, 02:51 PM
Date Of Original Report
May 17, 2024
Previous filing
Mar 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ReMed Common Stock Sale -$78.6K -360 -4.57% $218.29 7.52K May 15, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Amended to indicate that the transaction was conducted under a Rule 10b5-1 plan adopted February 2, 2024.